608 related articles for article (PubMed ID: 24469825)
1. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.
Fletcher CV; Staskus K; Wietgrefe SW; Rothenberger M; Reilly C; Chipman JG; Beilman GJ; Khoruts A; Thorkelson A; Schmidt TE; Anderson J; Perkey K; Stevenson M; Perelson AS; Douek DC; Haase AT; Schacker TW
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2307-12. PubMed ID: 24469825
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue.
Ruiz L; van Lunzen J; Arno A; Stellbrink HJ; Schneider C; Rull M; Castellà E; Ojanguren I; Richman DD; Clotet B; Tenner-Racz K; Racz P
AIDS; 1999 Jan; 13(1):F1-8. PubMed ID: 10207538
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence.
Freeling JP; Ho RJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):E2512-3. PubMed ID: 24889644
[No Abstract] [Full Text] [Related]
4. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
5. Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease.
Brodie SJ
J Leukoc Biol; 2000 Sep; 68(3):351-9. PubMed ID: 10985251
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals.
Cohen OJ; Pantaleo G; Schwartzentruber DJ; Graziosi C; Vaccarezza M; Fauci AS
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S6-14. PubMed ID: 8595512
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2.
Stellbrink HJ; Hufert FT; Tenner-Racz K; Lauer J; Schneider C; Albrecht H; Racz P; van Lunzen J
Antivir Ther; 1998; 3(4):209-14. PubMed ID: 10682140
[TBL] [Abstract][Full Text] [Related]
8. Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.
Cohen OJ; Pantaleo G; Lam GK; Fauci AS
Springer Semin Immunopathol; 1997; 18(3):305-22. PubMed ID: 9089951
[TBL] [Abstract][Full Text] [Related]
9. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
[TBL] [Abstract][Full Text] [Related]
10. Persistent HIV-1 replication during antiretroviral therapy.
Martinez-Picado J; Deeks SG
Curr Opin HIV AIDS; 2016 Jul; 11(4):417-23. PubMed ID: 27078619
[TBL] [Abstract][Full Text] [Related]
11. Overcoming pharmacologic sanctuaries.
Cory TJ; Schacker TW; Stevenson M; Fletcher CV
Curr Opin HIV AIDS; 2013 May; 8(3):190-5. PubMed ID: 23454865
[TBL] [Abstract][Full Text] [Related]
12. Are follicular dendritic cells, macrophages and interdigitating cells of the lymphoid tissue productively infected by HIV?
Tenner-Racz K; von Stemm AM; Gühlk B; Schmitz J; Racz P
Res Virol; 1994; 145(3-4):177-82. PubMed ID: 7800943
[TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
14. Lymph nodes during antiretroviral therapy.
Stellbrink HJ; van Lunzen J
Curr Opin Infect Dis; 2001 Feb; 14(1):17-22. PubMed ID: 11979110
[TBL] [Abstract][Full Text] [Related]
15. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
16. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.
Frenkel LM; Wang Y; Learn GH; McKernan JL; Ellis GM; Mohan KM; Holte SE; De Vange SM; Pawluk DM; Melvin AJ; Lewis PF; Heath LM; Beck IA; Mahalanabis M; Naugler WE; Tobin NH; Mullins JI
J Virol; 2003 May; 77(10):5721-30. PubMed ID: 12719565
[TBL] [Abstract][Full Text] [Related]
17. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
[TBL] [Abstract][Full Text] [Related]
18. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
Haase AT
Annu Rev Immunol; 1999; 17():625-56. PubMed ID: 10358770
[TBL] [Abstract][Full Text] [Related]
19. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.
Gianella S; Anderson CM; Var SR; Oliveira MF; Lada SM; Vargas MV; Massanella M; Little SJ; Richman DD; Strain MC; Pérez-Santiago J; Smith DM
J Virol; 2016 Apr; 90(8):3944-3952. PubMed ID: 26842469
[TBL] [Abstract][Full Text] [Related]
20. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
